gramine has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Ahmed, B; Kathiresan, S; Ramu, A | 1 |
| Bai, X; Meng, Z; Su, Y; Wang, Y; Xu, L; Yang, X; Zhuo, C | 1 |
2 other study(ies) available for gramine and transforming growth factor beta
| Article | Year |
|---|---|
Gramine inhibits angiogenesis and induces apoptosis via modulation of TGF-β signalling in 7,12 dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaloids; Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cheek; Cricetinae; Indole Alkaloids; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2017 |
Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; Indole Alkaloids; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta | 2023 |